While immunohistochemical OTP status cannot be used for subtyping PC tumours reliably, the absence of OTP expression is a strong indicator for aggressive disease progression and shorter disease-specific survival in PC tumour patients. This evidence concerns the gene OTP and pachyonychia congenita.